--- title: Gastroenterology CROs path: /indications/gastroenterology companies_count: 28 --- # Gastroenterology CROs 28 published CROs match Gastroenterology. Locations in this set include United States, China, France, Australia, Mexico, and United Kingdom. Capabilities that show up most often in this set: Regulatory Affairs, Clinical Operations, Phase I Clinical Trials, Phase II Clinical Trials, and Data Management & eClinical. ## Matching companies - [Accelsiors](/companies/accelsiors) - Full-service CRO providing clinical trial management, regulatory consulting, pharmacovigilance, biostatistics, and medical writing across 40+ countries with AI-secure eClinical systems and patient-centered trial design. - [Altasciences](/companies/altasciences) - Mid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities. - [Aragen Life Sciences](/companies/aragen) - Global CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe. - [CROss Alliance](/companies/croalliance) - Swiss-based CRO with over 500 completed clinical studies, specializing in Phase I research in healthy volunteers and special populations, supported by centralized clinical labs and analytical capabilities. - [Caidya](/companies/caidya) - Caidya is a global, full-service CRO delivering personalized clinical development solutions across all phases of clinical research. - [Certara](/companies/certara) - Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making. - [Clarenta](/companies/comac-medical) - Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases. - [Clario](/companies/clario) - Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade. - [ExperTrials](/companies/expertrials) - European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA. - [Fortrea](/companies/fortrea) - Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success. - [IQVIA](/companies/iqvia) - IQVIA is a global life sciences and healthcare company providing data, expertise, AI, analytics, and technology solutions to support clinical development and improve patient outcomes. - [InnoSer Laboratories](/companies/innoserlaboratories) - Preclinical CRO offering GLP and non-GLP toxicology, custom genetically modified mouse models, and disease models across oncology, neurology, immunology, metabolic, and cardiovascular research. Supports programs from target discovery through IND-enabling studies. - [Inotiv](/companies/inotivco) - Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases. - [KCAS Bio](/companies/kcasbio) - Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities. - [Medpace](/companies/medpace) - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit. - [Oncodesign Services](/companies/oncodesign-services) - Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995. - [PPD](/companies/ppd) - PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific. - [PSI](/companies/appian) - PSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases. - [Parexel](/companies/parexel) - Parexel is a comprehensive CRO offering end-to-end biopharmaceutical development services spanning portfolio optimization, early development, integrated clinical development, regulatory approval, and lifecycle value substantiation. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.